NCT05209256 Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC Status UNKNOWN Phase PHASE2/PHASE3
NCT05186506 A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05183984 Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer Status RECRUITING Phase PHASE2
NCT05183958 A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05170594 A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer Status UNKNOWN Phase PHASE2
NCT05145660 Optimization of Cervical Nodal CTV for Early and Medium Stage NPC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05111626 Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. Status TERMINATED Phase PHASE3
NCT05101616 A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer Status SUSPENDED Phase PHASE1/PHASE2
NCT05036005 Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) Status UNKNOWN Phase PHASE4
NCT05011227 Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma Status RECRUITING Phase PHASE2
NCT04997837 Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma Status RECRUITING Phase PHASE3
NCT04990063 Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC) Status UNKNOWN Phase PHASE1
NCT04975516 Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT04952480 Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT04951648 A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation Status UNKNOWN Phase PHASE3
NCT04917289 CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients Status NOT_YET_RECRUITING Phase PHASE3
NCT04905316 A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer Status COMPLETED Phase PHASE2